Prostate cancer : imaging, management and screeningSCHRÖDER, Fritz.The Prostate. 1992, issn 0270-4137, 169 p., SUP4Conference Proceedings

Round table discussionThe Prostate. 1992, pp 59-62, issn 0270-4137, SUP4Conference Paper

A rationale for the use of non-steroidal anti-androgens in the management of prostate cancerBENSON, R. C.The Prostate. 1992, pp 85-90, issn 0270-4137, SUP4Conference Paper

Magnetic resonance spectroscopy in prostate disease : diagnostic possibilities and future developmentsPERINCHERY NARAYAN; KURHANEWICZ, J.The Prostate. 1992, pp 43-50, issn 0270-4137, SUP4Conference Paper

Rectal examination and ultrasonography in the diagnosis of prostate cancerCOONER, W. H.The Prostate. 1992, pp 3-10, issn 0270-4137, SUP4Conference Paper

The management of bladder outlet obstruction due to prostate cancer, untreated and after endocrine treatmentMONTIE, J. E.The Prostate. 1992, pp 153-157, issn 0270-4137, SUP4Conference Paper

The molecular biology of urological tumorsTRAPMAN, J.The Prostate. 1992, pp 159-169, issn 0270-4137, SUP4Conference Paper

To screen or not to screen ?DENIS, L. J.The Prostate. 1992, pp 63-70, issn 0270-4137, SUP4Conference Paper

Complete androgen blockade in prostate cancer : an overview of randomized trialsDALESIO, O.The Prostate. 1992, pp 111-114, issn 0270-4137, SUP4Conference Paper

DNA content/ploidy as prognostic factors in prostate cancerLIEBER, M. M.The Prostate. 1992, pp 119-124, issn 0270-4137, SUP4Conference Paper

Estramustine phosphate and other cytotoxic drugs in the treatment of poor prognostic advanced prostate cancerJANKNEGT, R. A.The Prostate. 1992, pp 105-110, issn 0270-4137, SUP4Conference Paper

Prostate specific antigen in diagnosis, staging, and follow-up of prostate cancerCOOPER, E. H.The Prostate. 1992, pp 125-128, issn 0270-4137, SUP4Conference Paper

The position of cyproterone acetate (CPA), a steroidal anti-androgen, in treatment of prostate cancerDE VOOGT, H. J.The Prostate. 1992, pp 91-95, issn 0270-4137, SUP4Conference Paper

Indications and techniques of prostate biopsiesANDERSSON, L.The Prostate. 1992, pp 115-118, issn 0270-4137, SUP4Conference Paper

The natural history of locally confined prostate cancer : a reviewRAIR, W. R.The Prostate. 1992, pp 79-84, issn 0270-4137, SUP4Conference Paper

What is progression in prostate cancer ?NEMLING, D. W. W.The Prostate. 1992, pp 139-143, issn 0270-4137, SUP4Conference Paper

Casodex : a pure non-steroidal anti-androgen used as monotherapy in advanced prostate cancerTYRRELL, C. J.The Prostate. 1992, pp 97-104, issn 0270-4137, SUP4Conference Paper

The management of incidental T1aG1 (TNM 1987) prostate cancerSOLOWAY, M. S; ALTWEIN, J. E.The Prostate. 1992, pp 149-151, issn 0270-4137, SUP4Conference Paper

Functional urology towards the next millenniumJANKNEGT, R. A; VAN KERREBROECK, Philip E. V.European urology. 1998, Vol 34, issn 0302-2838, 57 p., SUP1Conference Proceedings

Magnetic resonance imaging in carcinma of the prostatePOLLACK, H. M; SCHNALL, M. D.The Prostate. 1992, pp 17-31, issn 0270-4137, SUP4Conference Paper

Automation in urodynamicsHÖFNER, K.European urology. 1998, Vol 34, pp 38-39, issn 0302-2838, SUP1Conference Paper

Investigational techniquesFOWLER, C. J.European urology. 1998, Vol 34, pp 10-12, issn 0302-2838, SUP1Conference Paper

The importance of the cholinergic system in neurourologyANDERSSON, K.-E.European urology. 1998, Vol 34, pp 6-9, issn 0302-2838, SUP1Conference Paper

Clinical aspects of detrusor instability and the value of urodynamicsZINNER, N. R.European urology. 1998, Vol 34, pp 16-19, issn 0302-2838, SUP1Conference Paper

Clinical aspects of detrusor instability and the value of urodynamics: A review of the evidenceGRIFFITHS, D.European urology. 1998, Vol 34, pp 13-15, issn 0302-2838, SUP1Conference Paper